Comparison of pyrantel pamoate and bephenium hydroxynaphthoate in the treatment of Ancylostoma duodenale infections.
D000284:Administration, Oral; D000724:Ancylostomiasis / Q000188:drug therapy*; D000871:Anthelmintics / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D001598:Bephenium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D004534:Egypt; D005243:Feces / Q000032:analysis; D006801:Humans; D009281:Naphthalenes / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D010270:Parasite Egg Count; D011725:Pyridines / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D013876:Thiophenes / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D014753:Vinyl Compounds / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use
D000871:Anthelmintics; D001598:Bephenium Compounds; D009281:Naphthalenes; D011725:Pyridines; D013876:Thiophenes; D014753:Vinyl Compounds